This hottest twist in the Lykos Therapeutics saga threatens An important overhaul of the company’s approach and way, with Musk ally and billionaire Trader Antonio Gracias showing up to want to just take the business back again toward its nonprofit drug development roots and a far more Doblinite philosophy.Are you currently able to take a journey